Covid Impact Oncology Drugs Market is expected to register a CAGR of 7.3%, reaching a value of around USD 223 billion by the end of 2027.


The Global Oncology Drugs Market is expected to register a CAGR of 7.3%, reaching a value of around USD 223 billion by the end of 2027.

Oncology is the branch of science deals with cancer and related treatment. Cancer or malignancy is referred to as the group of the diseases characterized by uncontrolled or abnormal growth of the cells. Oncology drugs or cancer drugs are dedicated to controlling, inhibiting or to kill the uncontrollable carcinogenic cells. These drugs can be prescribed alone or with any combination treatment or therapy. It includes chemotherapy, targeted therapy, pain killer, hormone therapy and immunotherapy.

Get Sample Copy of This Report @

ONCOLOGY DRUGS MARKET: Drivers & Challanges

Market Driver:

  • Rapidly Growing Cancer Incidence

The growing prevalence of cancer in global population creates an impact on the healthcare industry and society across the world. Cancer has gained the second position in the fatal diseases following cardiovascular diseases and contributing immensely to the global death rate with a remarkable rise in the incidence of new cases globally. In 2018, the World Health Organization stated that around 18.1 million fresh cases of cancer were reported. Whereas, American Cancer Society revealed that cancer is accountable for one in the six death globally. The incidence of fatal diseases can be attributed to various factors including growth in global population and increasing count of the elderly population. Cancer Research UK stated over three-quarters of the total cancer population is over 60 years. Smoking, life-style related factors, exposure to radioactive chemicals, and genetic factor further favors the incidence of the new cancer cases. . With the growing cancer cases worldwide, the oncology drugs market is growing at a robust rate

Market Challenge:

  • Side Effects Associated with Cancer Drugs

Different type of cancer drugs leads to different types of side effects including anemia, anorexia, infections, diarrhea, oral problems, weight loss, nausea and many more resulting in discomfort and extreme pain. Some of the treatment and drugs leave a long term impact including early menopause in females, extreme fatigue and impacting cognitive functioning. Due to serious side effects associated with the cancer drugs is expected to witness a roadblock for the oncology drug market.

Request for Methodology of This Report @

ONCOLOGY DRUGS market: Key segments

  • Segmentation based on form: Oral, Topical and IV
  • Segmentation based on type: Targeted Therapy, Immunotherapy, Chemotherapy, Hormone Therapy and Pain Killers
  • Segmentation based on cancer type: Prostate Cancer, Brain Cancer, Ovarian Cancer, Breast Cancer, Skin Cancer, Bladder Cancer, Colorectal Cancer, Blood Cancer and Other Types of Cancer
  • Segmentation based on region covers: North America, South America, Europe, Asia-Pacific, Middle East & Africa and South America, with individual country-level analysis.

KEY Companies Covered

  • F. Hoffmann-La Roche Ltd (Company Description, Company Overview, Product Synopsis, Key Developments, SWOT Analysis)
  • Abbott Laboratories
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Merck KGaA
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Eli Lilly and Company
  • AbbVie Inc.
  • AstraZeneca
  • Other Key Players

Consult with Analyst @

ONCOLOGY DRUGS MARKET: report segmentation

For the scope of the report, In-depth segmentation is offered by Forencis Research

Oncology Drugs Market, by Form

  • Oral
  • Topical
  • IV

Oncology Drugs Market, by Type

  • Targeted Therapy
  • Growth Blockers
  • Monoclonal Antibodies
  • Small Molecule Inhibitor
  • Others
  • Immunotherapy
  • Chemotherapy
  • Hormone Therapy
  • Pain Killers

Oncology Drugs Market, by Cancer Type

  • Prostate Cancer
  • Brain Cancer
  • Ovarian Cancer
  • Breast Cancer
  • Skin Cancer
  • Bladder Cancer
  • Colorectal Cancer
  • Blood Cancer
  • Other Types of Cancer

Oncology Drugs Market, by Region

  • North America
  • US
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Belgium
  • Rest of Europe
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • South America
  • Brazil
  • Argentina
  • Peru
  • Chile
  • Rest of South America

Customize this Industry Analysis @

Table of Content

  2. Research Objectives
  3. Market Definition
  4. Research Scope
  5. Regional Coverage
  6. Research Timeline
  7. Assumptions
  8. Limitations
  10. Introduction
  11. Primary Research
  12. Key Industry Expert Insight
  13. Secondary Research
  14. Vital Data from Secondary Sources
  15. Market Size Estimation
  16. Data Validation & Triangulation
  19. Introduction
  20. Drivers
  21. Rapidly Growing Cancer Incidence
  22. Growing Demand for Personalized Medicine
  23. Restraint
  24. High Cost Associated with Drug Development
  25. Opportunities
  26. Recent Approvals from Regulatory Authorities
  27. Higher Funding for Cancer Related Research
  28. Challenges
  29. Side-effects of Cancer Drugs
  31. Introduction
  32. Power of Buyers
  33. Power of Suppliers
  34. Intensity of Competition
  35. Challenges of Substitutes
  36. Challenges of New Entrants
  37. Macro-Economic Indicators
  38. GLOBAL ONCOLOGY DRUGS MARKET BY FORM, Market Size in USD Million (2019–2027)
  39. Introduction
  40. Oral
  41. Topical
  42. Intravenous
  43. GLOBAL ONCOLOGY DRUGS MARKET BY TYPE, Market Size in USD Million (2019–2027)
  44. Introduction
  45. Targeted Therapy
  46. Growth Blockers
  47. Monoclonal Antibodies
  48. Small Molecule Inhibitor
  49. Others
  50. Immunotherapy
  51. Chemotherapy
  52. Hormone Therapy
  53. Pain Killers
  54. GLOBAL ONCOLOGY DRUGS MARKET BY CANCER TYPE, Market Size in USD Million (2019–2027)
  55. Introduction
  56. Prostate Cancer
  57. Brain Cancer
  58. Ovarian Cancer
  59. Breast Cancer
  60. Skin Cancer
  61. Bladder Cancer
  62. Colorectal Cancer
  63. Blood Cancer
  64. Other Types of Cancer
  65. GLOBAL ONCOLOGY DRUGS MARKET BY REGION, Market Size in USD Million (2019–2027)
  66. North America
  67. US
  68. Canada
  69. Mexico
  70. Europe
  71. Germany
  72. UK
  73. France
  74. Italy
  75. Spain
  76. Russia
  77. Rest of Europe
  78. Asia-Pacific
  79. China
  80. India
  81. Japan
  82. South Korea
  83. Indonesia
  84. Malaysia
  85. Rest of Asia-Pacific
  86. Middle East and Africa
  87. Saudi Arabia
  88. UAE
  89. Israel
  90. South Africa
  91. Rest of Middle East and Africa
  92. South America
  93. Brazil
  94. Argentina
  95. Peru
  96. Chile
  97. Rest of South America
  99. Introduction
  100. Market Ranking/Share Analysis of Key Companies
  101. Company Benchmarking
  103. F. Hoffmann-La Roche Ltd
  104. Company Overview
  105. Financial Overview
  106. Products/Solutions/Services Offered
  107. Key Developments
  108. SWOT Analysis
  109. Abbott Laboratories
  110. Novartis AG
  111. Bristol-Myers Squibb Company
  112. Merck KGaA
  113. Johnson & Johnson Services, Inc.
  114. Pfizer Inc.
  115. Eli Lilly and Company
  116. AbbVie Inc.
  117. AstraZeneca
  118. Other Key Players
  120. Key Industry Expert Insights
  121. Primary Discussion Guide
  122. Customization Options

About Forencis Research

Forencis Research is a B2B market research, intelligence and advisory firm engaging in market research and consulting services across leading industries, globally. Our robust and meticulous research team provides high growth and niche syndicated reports, customized reports and consulting reports to the diverse global fortune clientele and intellectual institutions. Forencis Research database is a constantly evolving pool of reports and white paper studies which helps companies to foster accelerated revenue growth in global and regional markets. Forencis Research delivers market research and consulting reports on high growth markets to help companies dominate their competition and set themselves apart by attaining increased revenue growth. To enable exclusive insights around the target market, Forencis Research employs robust research Methodology & Design which includes data acquisition, data synthesis and data correlation, through Primary and Secondary Research. Through the obtained data, Top-down and bottom-up methods are exercised to attain and verify data sanity within the entire market. This market data is yet again correlated with Forencis Research’s internal database before presenting it in any of our final publications. These methods of data correlation and amalgamation benefit us to put forward accurate market estimates enabling our clients to transform their business, markets and most importantly their “REVENUES”.

Contact Us


Phone: +1 (720) 306 9020


For more market research insights, please visit



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store